To ask the Scottish Government whether it has considered expanding the eligibility for the drug, Paxlovid, to people aged over 50. The Scottish Medicines Consortium ( SMC) has collaborated with The National Institute for Health and Care Excellence (NICE) on a multiple technology appraisal (MTA) of all COVID-19 treatments (known as TA878).